ZIMMER BIOMET HOLDINGS, INC. is 14.6x more valuable than AVANOS MEDICAL, INC. by market capitalization ($17.06 B vs $1.17 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AVNS | ZBH |
|---|---|---|
| Market cap | $1.17 B | $17.06 B |
| US-listed rank | #2523 | #677 |
| Revenue (latest FY) | $701.20M | $8.23B |
| Net income (latest FY) | -$72.90M | $705.10M |
| Net margin | -10.4% | 8.6% |
| P/E (trailing FY) | - | 24.2 |
| SEC filings | 701 | 1,000 |
ZIMMER BIOMET HOLDINGS, INC. is 14.6x more valuable than AVANOS MEDICAL, INC. by market capitalization ($17.06 B vs $1.17 B).
In their latest fiscal years, AVANOS MEDICAL, INC. reported $701.20M in revenue while ZIMMER BIOMET HOLDINGS, INC. reported $8.23B.
Full pages: AVANOS MEDICAL, INC. and ZIMMER BIOMET HOLDINGS, INC., or browse the full rankings.